Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 13/20 | 0.72 |
| ▸ | LPAR2 | Q9HBW0 | 9/20 | 0.72 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.72 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid Monododecyl Ester SCHEMBL30724148 | 1.00 | LPAR3 (0.72) | LPAR3LPAR2LPAR1LPAR5 | |
| Trolamine SCHEMBL10437940 | 1.00 | LPAR3 (0.72) | LPAR3LPAR2LPAR1LPAR5 | |
| Phosphoric Acid Monotetradecyl Ester SCHEMBL9184936 | 1.00 | LPAR3 (0.72) | LPAR3LPAR2LPAR1LPAR5 | |
| Trolamine SCHEMBL10437955 | 1.00 | LPAR3 (0.72) | LPAR3LPAR2LPAR1LPAR5 | |
| Trolamine SCHEMBL10437956 | 1.00 | LPAR3 (0.72) | LPAR3LPAR2LPAR1LPAR5 | |
| Trolamine SCHEMBL11209409 | 1.00 | LPAR3 (0.72) | LPAR3LPAR2LPAR1LPAR5 | |
| Phosphoric Acid Monododecyl Ester SCHEMBL3470168 | 1.00 | LPAR3 (0.72) | LPAR3LPAR2LPAR1LPAR5 | |
| Phosphoric Acid Monododecyl Ester SCHEMBL322337 | 1.00 | LPAR3 (0.72) | LPAR3LPAR2LPAR1LPAR5 | |
| Hexadecyl Dihydrogen Phosphate SCHEMBL9302969 | 1.00 | LPAR3 (0.72) | LPAR3LPAR2LPAR1LPAR5 | |
| Phosphoric Acid Monodecyl Ester SCHEMBL10438564 | 1.00 | LPAR3 (0.72) | LPAR3LPAR2LPAR1LPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111321594-A | Waterproof antibacterial fabric finishing agent and application thereof | 京准化工技术(上海)有限公司 | 2020-06-23 | — | — | CN | disclosed |
| US-20080119551-A1 | SKIN COSMETICS COMPRISING A CYSTINE DERIVATIVE AND A CHEMICAL PEELING AGENT, A BACTERICIDE, AN ANIONIC SUFACTANT, OR A CATIONIC SURFACTANT | AJINOMOTO CO. INC (JP) | 2008-05-22 | — | — | US | disclosed |
| US-20040156802-A1 | Cosmetics or external preparations for skin | AJINOMOTO CO., INC. (JP) | 2004-08-12 | — | — | US | disclosed |
| EP-1374831-A1 | COMSETICS OR EXTERNAL PREPARAIOTNS FOR SKIN | Ajinomoto Co., Inc. (JP) | 2004-01-02 | — | — | EP | disclosed |
| EP-0555864-B1 | Composition for use in oral cavity | KAO CORP (JP) | 1996-05-01 | — | — | EP | disclosed |
| US-5374418-A | An antibacterial compound comprising a nitrogen-containing cation with a monoalkyl phosphate anion; rapid and continued disinfection with good taste | KAO CORPORATION (JP) | 1994-12-20 | — | — | US | disclosed |
| EP-0555864-A1 | Composition for use in oral cavity | KAO CORPORATION (JP) | 1993-08-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040156802-A1 | Cosmetics or external preparations for skin | CUTA, PSAP, CTH | LPAR3 1024/4885LPAR2 1133/4885LPAR1 843/4885 |
| US-20080119551-A1 | SKIN COSMETICS COMPRISING A CYSTINE DERIVATIVE AND A CHEMICAL PEELING AGENT, A BACTERICIDE, AN ANIONIC SUFACTANT, OR A CATIONIC SURFACTANT | CUTA, CTH, SRM | LPAR3 1638/4885LPAR2 1883/4885LPAR1 951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.